Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2017

The activity for stock options under the Company’s stock plans is as follows:

								Remaining
								weighted-
						Weighted-		average		Per share
						average		contractual		average
				Price per		exercise		terms		intrinsic
	Options			share		price		(in years)		value
Outstanding as of December 31, 2016		2,355,527		$0.60-$58.95		$	28.22		5.42	$	38.95
Granted		64,498			83.30		83.30
Exercised		(395,739	)	0.60-56.72			23.48
Forfeited		(63,173	)	24.52-58.95			43.74
Expired		(33	)		8.70		8.70
Outstanding as of September 30, 2017		1,961,080		0.60-83.30			30.49		4.83		64.61
Vested and exercisable as of September 30, 2017		1,166,512		0.60-83.30			22.89		4.63		72.21
Vested and expected to vest as of September 30, 2017		1,907,844		$0.60-$83.30		$	30.20		4.82	$	64.90

Summary of Restricted Stock Activity

Restricted stock activity for the nine months ended September 30, 2017, is summarized below:

							Weighted-
							average grant
			Performance and				date fair value
	Time-based		time-based		Total		per share

Unvested restricted stock units as of December 31, 2016		—		—		—	$	—
Granted		41,100		13,109		54,209		89.64
Vested		—		—		—		—
Forfeited/canceled		—		—		—		—
Unvested restricted stock units as of September 30, 2017		41,100		13,109		54,209	$	89.64
Unvested restricted stock awards outstanding as of December 31, 2016		—		—		—	$	—
Granted		20,789		20,785		41,574		91.52
Vested		—		—		—		—
Forfeited/canceled		—		—		—		—
Unvested restricted stock awards outstanding as of September 30, 2017		20,789		20,785		41,574	$	91.52
Unvested and expected to vest restricted stock awards outstanding as of September 30, 2017		17,024		17,027		34,051	$	91.52

Summary of Stock-based Compensation Expense

Stock-based compensation

Stock-based compensation expense recognized for the three months and nine months ended September 30, 2017 and September 30, 2016 was as follows:

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Stock-based compensation expense by type of award:
Stock option plan awards	$	2,012	$	1,858	$	5,811	$	5,063
Restricted stock units and restricted stock awards		402		—		450		—
Employee stock purchase plan		109		95		369		341
Total stock-based compensation expense	$	2,523	$	1,953	$	6,630	$	5,404

For the three months and nine months ended September 30, 2017 and September 30, 2016, stock-based compensation expense recognized under ASC 718, included in cost of revenues, sales and marketing expense, general and administrative expense, and research and development expense was as follows:

	Three months ended				Nine months ended
	September 30,				September 30,
	2017		2016		2017		2016
Cost of revenue	$	205	$	175	$	608	$	454
Research and development		260		223		733		561
Sales and marketing		407		318		1,069		859
General and administrative		1,651		1,237		4,220		3,530
Total stock-based compensation expense	$	2,523	$	1,953	$	6,630	$	5,404